Management of Other Gastric and Duodenal Neuroendocrine Tumors

Amanda M. Laird, Steven K. Libutti

Research output: Contribution to journalReview article

Abstract

Gastric and duodenal neuroendocrine tumors (NETs) are increasing in incidence as a result of increased detection and awareness of neuroendocrine tumors as distinct tumor types. The three types of gastric NETs and duodenal NETs have different etiologies and tumor-specific factors, such as grade, location, and hormone-production, and the clinical settings influence management. Options for treatment include removal by local endoscopic resection and surgical resection. Medical therapy is used to treat the inciting condition or as systemic therapy in advanced disease. Although the overall prognosis for most is good, higher grade tumors behave aggressively and have reduced survival.

Original languageEnglish (US)
Pages (from-to)253-266
Number of pages14
JournalSurgical Oncology Clinics of North America
Volume29
Issue number2
DOIs
StatePublished - Apr 2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Surgery

Keywords

  • Carcinoid tumor
  • Duodenal neuroendocrine tumor
  • Gastric neuroendocrine tumor
  • Neuroendocrine
  • Zollinger-Ellison syndrome

Fingerprint Dive into the research topics of 'Management of Other Gastric and Duodenal Neuroendocrine Tumors'. Together they form a unique fingerprint.

  • Cite this